Ivermectin API Manufacturers and Supply Chain
Several manufacturers produce the active pharmaceutical ingredient (API) for Ivermectin. Companies involved in the manufacturing or supply of Ivermectin API include those based in India, China, and other regions globally. Specific API manufacturers can be identified through industry databases and supplier directories that track pharmaceutical ingredient production.
Key producers of Ivermectin API have historically included companies like IOL Chemicals and Pharmaceuticals Ltd. and Marksans Pharma Ltd. in India. Global suppliers are essential for meeting the demand for Ivermectin, which is used in both human and veterinary medicines.
When does the patent for Ivermectin expire?
Ivermectin's primary patents have long since expired, allowing for generic production. For instance, the original patent for Ivermectin was granted to Merck & Co. in the 1970s. As of 2024, the drug is well within the public domain, meaning no single entity holds exclusive rights to its manufacture based on these foundational patents [1].
Who is manufacturing generic Ivermectin drugs?
Numerous pharmaceutical companies worldwide produce generic versions of Ivermectin drugs. These companies operate under different regulatory approvals in various countries. The availability of generic Ivermectin is widespread across many markets.
What is the regulatory status of Ivermectin?
The regulatory status of Ivermectin varies by indication and by country. In the United States, the Food and Drug Administration (FDA) has approved Ivermectin for human use in treating certain parasitic infections, such as onchocerciasis (river blindness) and strongyloidiasis [2]. The FDA has also approved Ivermectin products for veterinary use to prevent heartworm disease and treat internal and external parasites in animals [3]. The FDA has not approved Ivermectin for the treatment or prevention of COVID-19 [2].
How does Ivermectin work?
Ivermectin is an anthelmintic and anti-parasitic drug. It works by disrupting nerve and muscle function in parasites, leading to their paralysis and death. This mechanism makes it effective against a range of internal and external parasites.
What are the side effects of Ivermectin?
Common side effects of Ivermectin in humans can include dizziness, nausea, vomiting, diarrhea, stomach pain, and rash. More serious side effects, though rare, can occur, particularly at higher doses or when used for unapproved indications. It is crucial to use Ivermectin only as prescribed by a healthcare professional [2].
What is the difference between Ivermectin and other anti-parasitic drugs?
Ivermectin belongs to the macrocyclic lactone class of antiparasitic drugs. It is distinct from other classes of antiparasitic medications in its specific mechanism of action, spectrum of activity, and potential side effect profile. For example, praziquantel is another antiparasitic drug used for tapeworm and fluke infections but has a different chemical structure and mode of action.
What clinical data supports Ivermectin's use?
Extensive clinical data supports Ivermectin's efficacy and safety for its approved indications, such as onchocerciasis and strongyloidiasis. These approvals are based on rigorous clinical trials demonstrating its effectiveness in clearing parasitic infections and reducing associated morbidity [2]. Clinical trials investigating Ivermectin for other conditions, including COVID-19, have yielded varied results and have not led to regulatory approval for these uses by agencies like the FDA [2].
Sources:
[1] DrugPatentWatch.com
[2] U.S. Food & Drug Administration
[3] U.S. Food & Drug Administration